Related Experiment Videos
Implications of pharmacogenomics for anesthesia providers
Tori Ama1, Sou Bounmythavong, Jodee Blaze
1Ambulatory Care Anesthetist, Grand Strand Regional Medical Center, Myrtle Beach, South Carolina, USA.
AANA Journal
|November 12, 2010
Summary
Pharmacogenomics, the study of how genes affect drug response, offers potential for personalized anesthesia. Understanding genetic influences can improve patient outcomes and reduce adverse effects in anesthetic management.
Area of Science:
- Anesthesiology
- Pharmacogenomics
- Genetics
Background:
- Anesthesia practice involves significant interpatient variability in drug response.
- Pharmacogenomics is an emerging field studying the role of genetics in drug response.
- This variability necessitates personalized approaches to anesthetic management.
Purpose of the Study:
- To provide clinicians with foundational knowledge of pharmacogenomics.
- To explore the implications of pharmacogenomics in anesthesia.
- To focus on pharmacogenomic applications for commonly used anesthetic drugs.
Main Methods:
- Literature review of pharmacogenomics in anesthesia.
- Synthesis of current research on genetic influences on anesthetic drug response.
- Analysis of pharmacogenomic data for commonly used anesthetic agents.
Main Results:
- Pharmacogenomics is increasingly utilized in medicine and drug development.
- Genetic variations can predict patient responses to anesthetic agents.
- Understanding these variations can guide individualized anesthetic drug therapy.
Conclusions:
- Pharmacogenomic knowledge can enhance anesthetic management.
- Personalized drug therapy in anesthesia can improve outcomes and minimize toxicity.
- Pharmacogenomics should complement, not replace, traditional anesthetic considerations due to incomplete explanation of drug response variability.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...